Roya Mohadjer is responsible for government revenue growth across the Environment, Health, National Security and Infrastructure markets. Roya has over 15 years of business development experience in energy, envrionment, human health and performance, and defense systems and platforms. She fosters collaboration across government and commercial markets to optimize technology solutions for mission critical needs.

Dr. Amy Vinturella serves as a Senior Program Manager at Battelle, where she applies her extensive expertise in public health disaster preparedness, strategic planning, risk assessment, and program management. With over 20 years of experience, she has worked extensively with public health and emergency management specialists at all levels of government and the military. Amy's commitment to public health and safety is further underscored by her robust educational background, holding multiple degrees including a Doctor of Science in Environmental Science and Engineering.

Carl Blaesing is a Principal Research Scientist at Battelle, bringing decades of experience in occupational health and safety, environmental health, emergency preparedness, and disaster response. Starting his career as an enlisted US Navy hospital corpsman, he rapidly climbed the ranks and earned a commission as an Environmental Health Officer. Carl applies his academic credentials, including a Master of Public Health in Environmental Health and a Master of Science in Emergency and Disaster Management, to large-scale health initiatives at Battelle.

Colachis focuses on developing assistive technologies that improve the quality of life for individuals with physical or cognitive challenges. He is a key member of the Battelle NeuroLife® program and played a major role in the development and clinical execution of a neural bypass technology that restores conscious control of the fingers and hands to individuals with spinal cord injuries.

Gabe Meister is a Sr. Scientist with 20 years of experience working in the discovery and preclinical phases of vaccine and drug development. Dr. Meister has led multiple programs at Battelle that have resulted in FDA approval of novel therapeutics for the treatment of rare and life-threatening diseases. Most recently Dr. Meister leads a diverse group of scientists and engineers in developing novel drug delivery technologies.

Drew manages just over 300 staff engaged in pre-clinical and clinical research for both government and commercial clients. Drew’s team provides integrated scientific and technological capabilities in high hazard and biocontainment toxicology, assay development and validation services, and toxicology and pharmacology for support for investigational new drug studies. Drew and the members of his team also support clinical research through the Battelle Public Health Research Center in Baltimore, Maryland and provide onsite scientific support for the Centers for Disease Control and Prevention in Atlanta, GA.